Lidox 5 Patch
Product Images NDC 87234-0505

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Lidox 5 Patch (NDC 87234-0505). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Injecta Medcial Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

526bd98b C490 A9ca E063 6394a90ae272

Packaging label for Lidox 5 Patch, a Lidocaine 5% topical patch with 50 mg/g strength. The label lists the active ingredient as Lidocaine USP 700 mg per patch, details inactive components, usual storage instructions (20° to 25°C), and packaging size of 30 patches in 30 envelopes. Distributed by Injecta Medical LLC, Bay Harbor, FL.*

FDA Label Image

Each (Lidox Patch 8723450501 V3)

Lidox 5 Patch, Lidocaine Patch 5%, topical adhesive patch containing 50 mg/g lidocaine. The label includes active and inactive ingredients, usage instructions, warnings, and storage conditions. It is marked Rx only, distributed by Injecta Medical LLC. Each patch measures 10 cm by 14 cm.*

FDA Label Image

Package (Lidox Patch 8723450530 V3 Package)

Packaging label for Lidox 5 Lidocaine Patch 5%, a topical adhesive patch containing 50 mg/g lidocaine. The label indicates a package size of 30 patches (30 envelopes with 1 patch each) and includes inactive ingredients, storage instructions, usage warnings, and directions for use with illustrative diagrams. Distributed by Injecta Medical LLC.*

FDA Label Image

Chemical Structure Lidocaine (Chemical Structure Lidocaine)

Chemical structure of lidocaine, the active ingredient in Lidox 5 Patch, a 5% topical lidocaine patch by Injecta Medical LLC.*

FDA Label Image

Examples (Class Examples)

A data table listing drug classes and examples. Classes include Nitrates/Nitrites, Local anesthetics, Antineoplastic agents, Antibiotics, Antimalarials, Anticonvulsants, and Other drugs. Examples for each class are provided, such as lidocaine under Local anesthetics and phenobarbital under Anticonvulsants.*

FDA Label Image

Figure 1 (Figure 1 Lidocaine)

A line graph depicting plasma lidocaine concentration (ng/mL) over 72 hours, with time in hours on the x-axis and plasma lidocaine levels on the y-axis. The graph shows three distinct peaks and declines, indicating fluctuations in plasma lidocaine levels over time.*

FDA Label Image

Absorption Rate (Table 1 Lidocaine Patch)

A data table presenting pharmacokinetic information for Lidocaine 5% Patch applied to normal volunteers. It shows results for 3 patches (2100 mg) applied to the back, with an application area of 420 cm², dose absorbed of 64 ± 32 mg, maximum concentration (Cmax) of 0.13 ± 0.06 mcg/mL, and time to maximum concentration (Tmax) of 11 hours after 12 hours wearing time.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.